Summary
Sodium butyrate and cyclic AMP-stimulating agents (prostaglandin E1, papaverine, theophylline, and RO20-1724) caused reductions in the cell number (primarily due to reduction in cell division) when added individually to human melanoma cells in culture. However, the combination of sodium butyrate with one of the cyclic AMP-stimulating agents produced a marked reduction in cell number (primarily due to cell death).
Similar content being viewed by others
References
K. N. Prasad, Biol. Rev.50, 129 (1975).
K. N. Prasad and P. K. Sinha, In Vitro12, 125 (1975).
L. Helson, CA25, 264 (1975).
L. Helson, K. Lai and C. W. Young, Molec. Pharmac.23, 2917 (1974).
G. S. Johnson and I. Pastan, Nature New Biol.237, 267 (1972).
J. W. Krieder, M. Rosenthal and N. Lengle, J. natl Cancer Inst.50, 555 (1973).
J. W. Krieder, D. R. Wade, M. Rosenthal and T. Densley, J. natl Cancer Inst.54, 1457 (1975).
E. O'Keefe and P. Cautrecasas, Proc. natl Acad. Sci., USA71, 2500 (1974).
M. L. Steinberg and J. R. Whittaker, J. Cell Physiol.87, 265 (1976).
G. Wong and J. Pawelek, Nature New Biol.241, 218 (1973).
Author information
Authors and Affiliations
Additional information
Supported in part by BRSG grant RR-05357 awarded by Biomedical Research Support Grant Program, Division of Research Resources, National Institutes of Health. We thank Marianne Gaschler for her technical help.
Rights and permissions
About this article
Cite this article
Prasad, K.N., Sakamoto, A. Effect of sodium butyrate in combination with prostaglandin E1 and inhibitors of cyclic nucleotide phosphodiesterase on human amelanotic melanoma cells in culture. Experientia 34, 1575–1576 (1978). https://doi.org/10.1007/BF02034681
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02034681